BackArvinas Overview
Arvinas Inc

Arvinas Target Price

See Arvinas's analyst price targets ($14) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$9.39

Average Target Price

$14.1750.9% upside

6 analysts in the last 4 months

High: $20 | Low: $10

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-10Morgan Stanley$106.5% upsideOpen
2026-08-10Evercore ISI$1449.1% upsideOpen
2026-08-05WedbushRobert Driscoll$1227.8% upsideOpen
2026-08-04Wells Fargo$1117.1% upsideOpen
2026-05-13BTIG$1891.7% upsideOpen
2026-05-13Barclays$20113% upsideOpen
2026-03-18Truist FinancialSrikripa Devarakonda$106.5% upsideOpen
2026-02-24Wedbush$1117.1% upsideOpen
2025-12-17Barclays$1891.7% upsideOpen
2025-10-30BTIGJeet Mukherjee$1449.1% upsideOpen
2025-10-15Goldman Sachs$636.1% downsideOpen
2025-10-07Piper Sandler$1670.4% upsideOpen
2025-09-18BTIG$106.5% upsideOpen
2025-09-18StephensSudan Loganathan$1449.1% upsideOpen
2025-09-16Barclays$1670.4% upsideOpen
2025-06-02H.C. WainwrightAndrew Fein$24155.6% upsideOpen
2025-05-05Truist FinancialSrikripa Devarakonda$1117.1% upsideOpen
2025-05-02BTIGJeet Mukherjee$1670.4% upsideOpen
2025-03-13Morgan Stanley$1227.8% upsideOpen
2025-03-12BMO CapitalEtzer Darout$20113% upsideOpen
2025-03-12Wells FargoDerek Archila$26176.9% upsideOpen
2024-12-10BTIGJeet Mukherjee$69634.8% upsideOpen
2024-11-19Leerink PartnersChristopher Liu$62560.3% upsideOpen
2024-10-31OppenheimerMatthew Biegler$40326% upsideOpen
2024-10-21Stifel NicolausBradley Canino$63570.9% upsideOpen
2024-05-16OppenheimerMatthew Biegler$70645.5% upsideOpen
2024-04-12H.C. WainwrightAndrew Fein$87826.5% upsideOpen
2024-04-11Stifel NicolausBradley Canino$72666.8% upsideOpen
2023-12-19Wells FargoDerek Archila$63570.9% upsideOpen
2023-10-23WedbushRobert Driscoll$24155.6% upsideOpen
2023-01-03Wells Fargo$49421.8% upsideOpen
2022-12-05Citigroup$72666.8% upsideOpen
2022-11-23Barclays$70645.5% upsideOpen
2022-11-22Piper SandlerEdward Tenthoff$81762.6% upsideOpen
2022-11-11Morgan Stanley$57507% upsideOpen
2022-02-18WedbushRobert Driscoll$98943.7% upsideOpen
2022-02-09Wells FargoDerek Archila$98943.7% upsideOpen
2021-09-09Bank of America SecuritiesTazeen Ahmad$1101071.5% upsideOpen
2021-08-05Piper SandlerEdward Tenthoff$1251231.2% upsideOpen
2021-05-20UBSEliana Merle$1231209.9% upsideOpen

Arvinas (ARVN) FAQ

The latest target price for ARVN is $14. Investors often review this figure alongside Arvinas's historical trend and sector peers before judging valuation or financial health.

Arvinas trades near $9.39 while the consensus target sits at $14 (50.9% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting ARVN's target price ($14), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Arvinas's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.